Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Natural killer (NK) cells are innate lymphoid cells (ILCs) crucial for eliminating stressed, cancerous, and virally infected cells.
• NK cells also regulate immune responses via cytokine production and influence non-immune processes like vascular remodeling.
• NK cell-based therapies show promise in preclinical and clinical settings for cancer treatment.

Purpose of the Study:

• To review current NK cell-based cancer therapies.
• To examine challenges posed by tumor-induced NK cell suppression and plasticity.
• To discuss strategies for overcoming these challenges and explore non-cancer applications.

Main Methods:

• Review of existing literature on NK cell function, cancer therapies, and tumor microenvironment.
• Analysis of factors contributing to NK cell suppression and plasticity.
• Synthesis of ongoing research and future directions in NK cell therapy.

Main Results:

• Tumor microenvironment factors like TGF-β, hypoxia, and IDO suppress NK cell function.
• These factors induce NK cell plasticity, converting cytotoxic NK cells into less effective phenotypes.
• Current NK cell therapies face limitations due to these suppressive mechanisms.

Conclusions:

• Overcoming tumor-linked NK cell suppression and plasticity is critical for enhancing cancer therapy efficacy.
• Developing strategies to maintain NK cell function within the tumor microenvironment is essential.
• NK cell therapies hold potential beyond cancer treatment, including roles in immune regulation and tissue repair.